Omega Healthcare Investors Inc.

06/05/2026 | Press release | Distributed by Public on 06/05/2026 14:16

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 5, 2026, Omega Healthcare Investors, Inc. ("Omega" or the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the holders of 255,926,290 shares of Omega's common stock were present in person or represented by proxy, representing approximately 85.93% of the total outstanding common stock as of the record date for the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal 1: Election of Directors

FOR AGAINST ABSTENTIONS BROKER NON-VOTES
Kapila K. Anand 207,267,529 6,458,915 372,859 41,826,987
Craig R. Callen 206,030,608 7,709,158 359,537 41,826,987
Dr. Lisa C. Egbuonu-Davis 209,507,298 3,824,288 767,717 41,826,987
Barbara B. Hill 206,904,705 6,837,458 357,140 41,826,987
Kevin J. Jacobs 212,039,448 1,703,885 355,970 41,826,987
C. Taylor Pickett 211,101,005 2,613,356 384,942 41,826,987
Stephen D. Plavin 198,442,058 15,286,082 371,163 41,826,987
Burke W. Whitman 208,122,149 5,606,187 370,967 41,826,987

Proposal 2: Proposal to Ratify the Selection of Ernst & Young LLP as Omega's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026

For Against Abstentions Broker Non-Votes
240,521,117 14,949,017 456,156 Not applicable

Proposal 3: Advisory Vote on Executive Compensation

For Against Abstentions Broker Non-Votes
202,883,780 10,248,851 966,672 41,826,987

Each of the director nominees was elected, the selection of Ernst & Young LLP was ratified and Omega's executive compensation was approved on an advisory basis.

Item 8.01 Other Events.

The Company is providing updated information regarding the beneficial ownership of its common stock by directors, executive officers, and holders of more than 5% of the Company's outstanding shares. On March 27, 2026, The Vanguard Group filed an amendment to its Schedule 13G reporting that it no longer had, or was deemed to have, beneficial ownership of the Company's shares based on an internal corporate realignment. After the Company filed its proxy statement for the Annual Meeting, two affiliated entities of The Vanguard Group reported beneficial ownership, on a disaggregated basis, of more than 5% of the Company's outstanding common stock. The Company has determined to update the beneficial ownership information for all persons known to the Company to be the beneficial owner of more than 5% of the Company's outstanding common stock to reflect the most current Schedule 13G filings available as of the date of this report.

Based on this information and Schedule 13G filings with respect to the Company's common stock, the beneficial ownership of the Company's common stock as of April 8, 2026, for all persons known to the Company to be the beneficial owner of more than 5% of the Company's outstanding common stock, is set forth in the following table:

Omega Healthcare Investors Inc. published this content on June 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on June 05, 2026 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]